Prevalence of biofilms in acute infections challenges a longstanding paradigm

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Prevalence of biofilms in acute infections challenges a longstanding paradigm. / Kolpen, Mette; Jensen, Peter Østrup; Faurholt-Jepsen, Daniel; Bjarnsholt, Thomas.

In: Biofilm, Vol. 4, 100080, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kolpen, M, Jensen, PØ, Faurholt-Jepsen, D & Bjarnsholt, T 2022, 'Prevalence of biofilms in acute infections challenges a longstanding paradigm', Biofilm, vol. 4, 100080. https://doi.org/10.1016/j.bioflm.2022.100080

APA

Kolpen, M., Jensen, P. Ø., Faurholt-Jepsen, D., & Bjarnsholt, T. (2022). Prevalence of biofilms in acute infections challenges a longstanding paradigm. Biofilm, 4, [100080]. https://doi.org/10.1016/j.bioflm.2022.100080

Vancouver

Kolpen M, Jensen PØ, Faurholt-Jepsen D, Bjarnsholt T. Prevalence of biofilms in acute infections challenges a longstanding paradigm. Biofilm. 2022;4. 100080. https://doi.org/10.1016/j.bioflm.2022.100080

Author

Kolpen, Mette ; Jensen, Peter Østrup ; Faurholt-Jepsen, Daniel ; Bjarnsholt, Thomas. / Prevalence of biofilms in acute infections challenges a longstanding paradigm. In: Biofilm. 2022 ; Vol. 4.

Bibtex

@article{38ab20584a2a474ab7605c479e0902b0,
title = "Prevalence of biofilms in acute infections challenges a longstanding paradigm",
abstract = "The significance of bacterial biofilm formation in chronic bacterial lung infections has long been recognized [1]. Likewise, chronic biofilm formation on medical devices is well accepted as a nidus for recurrent bacteremia [2,3]. Even though the prevailing paradigm relies on the dominance of planktonic bacteria in acute endobronchial infections, our understanding of the bacterial organization during acute infection is, so far, limited - virtually absent. However, by comparing similar clinical samples, we have recently demonstrated massive bacterial biofilm formation during acute lung infections resembling the immense bacterial biofilm formation during chronic lung infections. These findings pose major challenges to the basic paradigm of chronic infections being dominated by biofilm forming bacteria while acute infections are dominated by planktonic bacteria. As opposed to the similar high amount of bacterial biofilm found in chronic and acute lung infections, we found that the fast bacterial growth in acute lung infections differed from the slow bacterial growth in chronic lung infections. By highlighting these new findings, we review modes of improved treatment of biofilm infections and the relevance of bacterial growth rates for other bacterial biofilm infections than human lung infections.",
author = "Mette Kolpen and Jensen, {Peter {\O}strup} and Daniel Faurholt-Jepsen and Thomas Bjarnsholt",
note = "Publisher Copyright: {\textcopyright} 2022",
year = "2022",
doi = "10.1016/j.bioflm.2022.100080",
language = "English",
volume = "4",
journal = "Biofilm",
issn = "2590-2075",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Prevalence of biofilms in acute infections challenges a longstanding paradigm

AU - Kolpen, Mette

AU - Jensen, Peter Østrup

AU - Faurholt-Jepsen, Daniel

AU - Bjarnsholt, Thomas

N1 - Publisher Copyright: © 2022

PY - 2022

Y1 - 2022

N2 - The significance of bacterial biofilm formation in chronic bacterial lung infections has long been recognized [1]. Likewise, chronic biofilm formation on medical devices is well accepted as a nidus for recurrent bacteremia [2,3]. Even though the prevailing paradigm relies on the dominance of planktonic bacteria in acute endobronchial infections, our understanding of the bacterial organization during acute infection is, so far, limited - virtually absent. However, by comparing similar clinical samples, we have recently demonstrated massive bacterial biofilm formation during acute lung infections resembling the immense bacterial biofilm formation during chronic lung infections. These findings pose major challenges to the basic paradigm of chronic infections being dominated by biofilm forming bacteria while acute infections are dominated by planktonic bacteria. As opposed to the similar high amount of bacterial biofilm found in chronic and acute lung infections, we found that the fast bacterial growth in acute lung infections differed from the slow bacterial growth in chronic lung infections. By highlighting these new findings, we review modes of improved treatment of biofilm infections and the relevance of bacterial growth rates for other bacterial biofilm infections than human lung infections.

AB - The significance of bacterial biofilm formation in chronic bacterial lung infections has long been recognized [1]. Likewise, chronic biofilm formation on medical devices is well accepted as a nidus for recurrent bacteremia [2,3]. Even though the prevailing paradigm relies on the dominance of planktonic bacteria in acute endobronchial infections, our understanding of the bacterial organization during acute infection is, so far, limited - virtually absent. However, by comparing similar clinical samples, we have recently demonstrated massive bacterial biofilm formation during acute lung infections resembling the immense bacterial biofilm formation during chronic lung infections. These findings pose major challenges to the basic paradigm of chronic infections being dominated by biofilm forming bacteria while acute infections are dominated by planktonic bacteria. As opposed to the similar high amount of bacterial biofilm found in chronic and acute lung infections, we found that the fast bacterial growth in acute lung infections differed from the slow bacterial growth in chronic lung infections. By highlighting these new findings, we review modes of improved treatment of biofilm infections and the relevance of bacterial growth rates for other bacterial biofilm infections than human lung infections.

U2 - 10.1016/j.bioflm.2022.100080

DO - 10.1016/j.bioflm.2022.100080

M3 - Journal article

C2 - 35721391

AN - SCOPUS:85132337328

VL - 4

JO - Biofilm

JF - Biofilm

SN - 2590-2075

M1 - 100080

ER -

ID: 313377836